Vuja De Sciences
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
827 Bloomfield St Apt 300, Hoboken, New ...Phone Number
(508) 650-6218Website
www.vujade-life.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Vuja De Sciences
Vuja De Sciences focuses on targeting undetected microscopic metastatic tumors, which are responsible for the progression of cancer and the majority of cancer fatalities. Their novel proprietary anti-metastatic progression discovery platform aims to identify drugs that target Metastatic Endurance, addressing the unique vulnerabilities of persistent, dormant tumors that can lead to recurrence. The company's approach is designed to prevent overt and deadly metastatic recurrence, effectively combating a major challenge in cancer treatment. Their intended clients include cancer patients who are at risk of metastasis and require innovative therapeutic solutions.Explore more
Vuja De Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vuja De Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Vuja De Sciences is spiking on competitors!
Funding: Get notified immidiatlly once Vuja De Sciences has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vuja De Sciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vuja De Sciences
Check if Vuja De Sciences has recently received funding, and reach out quickly before it becomes old news!
Vuja De Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vuja De Sciences had a recent Job posting/layoffs
Product Launch: Get notified when Vuja De Sciences launches new products
Recommended Actions
Find VP level buyers at Vuja De Sciences
Find more new buyers
Compare Similar Companies to Vuja De Sciences
Compare insights from companies similar to Vuja De Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Vuja De Sciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Vuja De Sciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Vuja De Sciences.
Vuja De Sciences Tech Stack
A closer look at the technologies used by Vuja De Sciences
Vuja De Sciences News & Media
HebeCell and Vuja De Sciences Announce Strategic Collaboration
Signed R&D collaboration agreement and a memorandum of understanding to develop and commercialize game-changing cancer therapies based on iPSC-derived NK cells in combination with small molecule drugs for preventing and treating metastatic cancer, the cause of 90% of cancer deaths (PRWeb April 06, 2022) Read the full story at https://www.prweb.com/releases/2022/4/prweb18598127.htmVuja De Sciences Announces Appointment of Translational Medicine and...
New board member brings extensive experience in elucidating the biology of metastatic cancer progression and leading translational medicine approaches at the National Cancer Institute and at leading... (PRWeb December 21, 2021) Read the full story at https://www.prweb.com/releases/vuja_de_sciences_announces_appointment_of_translational_medicine_and_cancer_metastasis_research_pioneer_to_board_of_directors/prweb18403917.htm
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Vuja De Sciences
Sign Up For FreeTo access detailed company insights
Vuja De Sciences focuses on targeting undetected microscopic metastatic tumors, which are responsible for the progression of cancer and the majority of cancer fatalities. Their novel proprietary anti-metastatic progression discovery platform aims to identify drugs that target Metastatic Endurance, addressing the unique vulnerabilities of persistent... Read More
